These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19732979)

  • 1. Use of Impella Recover LP 2.5 in elective high risk percutaneous coronary intervention.
    Ferreiro JL; Gómez-Hospital JA; Cequier ÁR; Angiolillo DJ; Roura G; Teruel L; Maristany J; Gómez-Lara J; Jara F; Bass TA; Esplugas E
    Int J Cardiol; 2010 Nov; 145(2):235-237. PubMed ID: 19732979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Impella Recover 2.5 left ventricular assist device in patients with cardiogenic shock or undergoing high-risk percutaneous coronary intervention procedures: experience of a high-volume center.
    Vecchio S; Chechi T; Giuliani G; Lilli A; Consoli L; Spaziani G; Giannotti F; Margheri M
    Minerva Cardioangiol; 2008 Aug; 56(4):391-9. PubMed ID: 18614983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the Impella 2.5 in high-risk percutaneous coronary intervention.
    McCulloch B
    Crit Care Nurse; 2011 Feb; 31(1):e1-16. PubMed ID: 21285459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk left main coronary stenting supported by percutaneous Impella Recover LP 2.5 assist device.
    Cohen R; Domniez T; Elhadad S
    J Invasive Cardiol; 2007 Oct; 19(10):E294-6. PubMed ID: 17906353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-risk PCI in acute coronary syndromes with Impella LP 2.5 device support.
    Iliodromitis KE; Kahlert P; Plicht B; Hoffmann AC; Eggebrecht H; Erbel R; Konorza TF
    Int J Cardiol; 2011 Nov; 153(1):59-63. PubMed ID: 20826017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with the Impella Recover LP 2.5 micro-axial pump in patients undergoing high-risk coronary angioplasty.
    Thomopoulou S; Manginas A; Cokkinos DV
    Hellenic J Cardiol; 2008; 49(6):382-7. PubMed ID: 19110924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.
    Henriques JP; Remmelink M; Baan J; van der Schaaf RJ; Vis MM; Koch KT; Scholten EW; de Mol BA; Tijssen JG; Piek JJ; de Winter RJ
    Am J Cardiol; 2006 Apr; 97(7):990-2. PubMed ID: 16563902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First Canadian experience with high-risk percutaneous coronary intervention with assistance of a percutaneously deployed left ventricular assist device.
    Eichhöfer J; Osten M; Horlick E; Dzavík V
    Can J Cardiol; 2008 Nov; 24(11):e82-5. PubMed ID: 18987766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hemolysis associated with use of the Impella LP 2.5 mechanical assist device.
    Sibbald M; Džavík V
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):840-4. PubMed ID: 22511273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term mechanical circulatory support with the Impella 5.0 device for cardiogenic shock at La Pitié-Salpêtrière.
    Mastroianni C; Bouabdallaoui N; Leprince P; Lebreton G
    Eur Heart J Acute Cardiovasc Care; 2017 Feb; 6(1):87-92. PubMed ID: 26873912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde recanalization of left main from saphenous vein graft supported by percutaneous Impella Recover LP 2.5 assist device.
    Burzotta F; Trani C; Coroleu S
    J Invasive Cardiol; 2009 Aug; 21(8):E147-50. PubMed ID: 19652264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impella ventricular assist device: use in patients at high risk for coronary interventions: successful multivessel percutaneous coronary intervention in a 62-year-old high-risk patient.
    Marella PC; Lassetter JE; Heuser RR
    Cardiovasc Revasc Med; 2011; 12(1):69.e9-12. PubMed ID: 21036108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impella Recover microaxial left ventricular assist device reduces mortality for postcardiotomy failure: a three-center experience.
    Siegenthaler MP; Brehm K; Strecker T; Hanke T; Nötzold A; Olschewski M; Weyand M; Sievers H; Beyersdorf F
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):812-22. PubMed ID: 15001911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impella 2.5 assisted balloon aortic valvuloplasty and percutaneous coronary intervention as a bridge to heart transplantation.
    Badawi RA; Grise MA; Thornton SN
    J Invasive Cardiol; 2012 May; 24(5):229-30. PubMed ID: 22562918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.